The pharmacokinetics of oral cyclosporin A (Neoral) during the first month after bone marrow transplantation.
Schultz
K R
KR
Department of Pediatrics, University of British Columbia, Vancouver, Canada.
Nevill
T J
TJ
Toze
C L
CL
Corr
T
T
Currie
C
C
Strong
D K
DK
Keown
P A
PA
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000367:Age Factors; D016026:Bone Marrow Transplantation / Q000276:immunology* / Q000502:physiology; D002648:Child; D002675:Child, Preschool; D016572:Cyclosporine / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D006086:Graft vs Host Disease / Q000517:prevention & control; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D007223:Infant; D007262:Infusions, Intravenous; D007408:Intestinal Absorption; D008657:Metabolic Clearance Rate; D008875:Middle Aged; D015203:Reproducibility of Results; D013997:Time Factors
D007166:Immunosuppressive Agents; D016572:Cyclosporine